News & Media

PRINCETON, N.J. & ROCKVILLE, Md. (September 29, 2020) – Otsuka America Pharmaceutical, Inc., (Otsuka) today announced that it is Great Place to Work-Certified™. Certification is a significant achievement. Using validated employee feedback gathered with Great Place to Work’s rigorous, data-driven “For All” methodology, Certification confirms at least seven out of 10 employees have a

Effort is part of the Accelerating Medicines Partnership to promote development of effective, targeted treatments.The National Institutes of Health is launching a new public-private partnership to meet the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. Part of the Accelerating Medicines Partnership (AMP), AMP Schizophrenia (SCZ) brings together

PRINCETON, N.J. (August 25, 2020) – Otsuka America Pharmaceutical, Inc., (Otsuka) today announces that it has purchased the assets of Proteus Digital Health, Inc. (Proteus), including assets and intellectual property for its ingestible and wearable sensor technology. This milestone in the evolution of Otsuka’s digital medicine program strengthens its research and product development plan for

July 8, 2020 – Princeton, N.J. – Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announces the launch of NephU (www.nephu.org) (formerly PKDnetwork), a community and online resource library designed for healthcare professionals working in nephrology (study of the kidney) to help engage, collaborate, and share resources for people living with kidney disease. NephU